Vaccination with B16 tumor cell lysate plus recombinant mycobacterium tuberculosis Hsp70 induces antimelanoma effect in mice

Cancer Biotherapy and Radiopharmaceuticals

Volumn 25, Issue 2, 2010, Pages 185-191

  Wang, Liying ^b   Li, He ^a   Yu, Yongli ^a   Sun, Luguo ^b   Wang, Hua ^b   Zhang, Peiyin ^b   Wei, Hongfei ^b   Weng, Li ^a   Wan, Min ^b   Cao, Zhao ^b   Wang, Ying ^b   Chen, Yajing ^a   Dong, Bohan ^b  

^a Basic Medical College   (China)

^b BEIHUA UNIVERSITY   (China)

Author keywords

Antitumor immunity; Hsp70; Mycobacterium tuberculosis; Tumor cell lysate; Vaccine

Indexed keywords

HEAT SHOCK PROTEIN 70;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL LYSATE; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; MELANOMA B16; MELANOMA CELL; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY;

ANIMALS; BACTERIAL PROTEINS; CANCER VACCINES; COMBINED MODALITY THERAPY; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HSP70 HEAT-SHOCK PROTEINS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SURVIVAL RATE; VACCINATION;

EID: 77951958848     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2009.0716     Document Type: Article

References (20)

1. Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocytemacrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci U S A 1993;90:3539.
2. Noessner E, Gastpar R, Milani V, et al. Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells. J Immunol 2002;169:5424.
3. Bendz H, Ruhland SC, Pandya MJ, et al. Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling. J Biol Chem 2007;282:31688.
4. 8+T cell epitopes fused to heat shock cognate protein 70 (hsc70) can function to eradicate tumors. Cancer Sci 2008;99:1008.
5. Castelli C, Ciupitu AM, Rini F, et al. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res 2001;61:222.
6. Hashemi SM, Hassan ZM, Soudi S, et al. The effect of vaccination with the lysate of heat-shocked tumor cells on nitric oxide production in BALB/c mice with fibrosarcoma tumor. Cell Biol Int 2008;32:835.
7. Koide T, Iinuma H, Fukushima R. Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70. Oncol Rep 2009;21:737.
8. Chen CH, Wang TL, Hung CF, et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 2000;60:1035.
9. Lan YH, Li YG, Liang ZW, et al. A DNA vaccine against chimeric AFP enhanced by HSP70 suppresses growth of hepatocellular carcinoma. Cancer Immunol Immunother 2007;56:1009.
10. Tobian AA, Harding CV, Canaday DH. Mycobacterium tuberculosis heat shock fusion protein enhances class I MHC cross-processing and-presentation by B lymphocytes. J Immunol 2005;174:5209.
11. Ma JH, Sui YF, Ye J, et al. Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo. Cancer Immunol Immunother 2005;54:907.
12. Li Z. In vitro reconstitution of heat shock proteinpeptide complexes for generating peptide-specific vaccines against cancers and infectious diseases. Methods 2004;32:25.
13. Ponomarev ED, Tarasenko TN, Sapozhnikov AM. Splenic cytotoxic cells recognize surface HSP70 on cultureadapted EL-4 mouse lymphoma cells. Immunol Lett 2000;74:133.
14. Yamazaki K, Nguyen T, Podack ER. Cutting edge: Tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. J Immunol 1999;163:5178.
15. Wang Y, Kelly CG, Karttunen JT, et al. CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 2001;15:971.
16. Geiger JD, Hutchinson RJ, Hohenkirk LF, et al. Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. Cancer Res 2001;61:8513.
17. Jones VE, Mitchell MS. Therapeutic vaccines for melanoma: Progress and problems. Trends Biotechnol 1996;14:349.
18. Feng Z, Huang B, Zhang G, et al. Investigation on the effect of peptides mixture from tumor cells inducing anti-tumor specific immune response. Sci China C Life Sci 2002;45:361.
19. Blachere NE, Li Z, Chandawarkar RY, et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J Exp Med 1997;186:1315.
20. Varesio L, Giovarelli M, Landolfo S, et al. Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor. Cancer Res 1979;39:4983.